Public Company News

2025 AACR | Abbisko Therapeutics Presents Late-Breaking Pre-clinical Research Results on ABSK112 (EGFR exon20ins), ABSK131 (PRMT5*MTA), and ABK-KRAS-1

SHANGHAI, April 27, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics 02256.HK) today announced that it has presented four late-breaking pre-clinical research posters at the 2025 AACR conference held in Chicago, Illinois (USA) from April 25 to April 30. Results were shared ...

2025-04-28 10:00 2152

Appotronics Debuts Full-Vehicle Optical System at Shanghai Auto Show

SHANGHAI, April 27, 2025 /PRNewswire/ -- At Auto Shanghai 2025, Appotronics (688007.SH), the inventor of ALPD® laser display technology, unveiled its groundbreaking Lingjing Intelligent Automotive Optical System – a comprehensive solution enabling dynamic projections on any vehicle surface, both ...

2025-04-27 21:45 2561

ARBOR Technology to Showcase Latest Automation Solutions at Automate 2025, Powering Machine Vision, AMR, and Smart Retail Applications

DETROIT, April 26, 2025 /PRNewswire/ -- ARBOR Technology, a leading provider of industrial-grade embedded computing solutions, is excited to announce its participation in Automate 2025, taking place inDetroit, USA, from May 12–15. Located in Hall E, Booth #9126.

2025-04-26 21:54 3188

51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year of 2024

SINGAPORE, April 25, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced  that it filed its annual report on Form 20-F for the fiscal year ended December 31, 202...

2025-04-26 08:30 4862

Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

BEIJING, April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it filed its annual report on Form 20-F for t...

2025-04-26 06:00 4340

Zepp Health Corporation Files 2024 Annual Report on Form 20-F

MILPITAS, Calif., April 25, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for the full year endedDecember 31, 2024 with the U.S....

2025-04-26 05:00 4511

Amcor to report fiscal 2025 third quarter results

ZURICH, April 25, 2025 /PRNewswire/ -- Amcor plc ("Amcor") (NYSE: AMCR, ASX: AMC) will announce its fiscal 2025 third quarter results for the three month period endedMarch 31, 2025, after the U.S. market closes on Wed., April 30, 2025. 

2025-04-26 04:12 4363

MDJM LTD Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel

LETHAM, Scotland, April 25, 2025 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that the Company received a staff determination letter (the "Letter"), onApril 23, 2025, from the Listing Qualification...

2025-04-26 04:05 3970

Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical Products Administration (NMPA) for its supplementary New D...

2025-04-26 01:24 3073

Baidu Launches ERNIE 4.5 Turbo, ERNIE X1 Turbo and New Suite of AI Tools to Empower Developers and Supercharge AI Innovation

* Following the release of two models in mid-March, Baidu unveiled ERNIE 4.5 Turbo and ERNIE X1 Turbo today, which stand out for their multimodal capabilities, strong reasoning, and low costs. ERNIE 4.5 Turbo delivers faster responses while priced at 20% of ERNIE 4.5; ERNIE X1 Turbo, featuring ...

2025-04-26 01:03 3981

Neusoft Launches Three Product Portfolios for AI-Powered Intelligent Mobility at Auto Shanghai 2025

SHANGHAI, April 25, 2025 /PRNewswire/ -- Recently, at Auto Shanghai 2025, Neusoft Corporation (Neusoft, SSE:600718) announced the launch of three core product portfolios: Neusoft A³ Cockpit-Driving-Parking Platform, Neusoft NeuMind Empowerment System for automotive industry, and OneCoreGo® Global...

2025-04-25 21:48 2762

ReTo Eco-Solutions, Inc. Announces Acquisition of Majority Interest in MeinMalzeBier Holdings Limited

BEIJING, April 25, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a manufacturer of ecological environment protection equipment and intelligent equipment inChina, today announced that on April 25, 2025, it has closed the acquisition of 51% equity interest ...

2025-04-25 21:15 4528

Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation

BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, announced a Letter to Investors, in which Baijiayun CEO Mr.Yi Ma stated that following its partnership with Xinlantian, the company plans to invest tens...

2025-04-25 21:10 3923

Hesai's AT Series Powers Cadillac's Innovative In-Cabin Lidar Integration in New VISTIQ SUV

SHANGHAI, April 25, 2025 /PRNewswire/ -- Hesai Group (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotic applications, announced that its long-range, automotive-grade AT series lidar has been selected by SAIC-GM for integration into Cadillac's new all-electri...

2025-04-25 20:30 2316

KB FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 25, 2025 /PRNewswire/ -- On April 25, 2025, KB Financial Group Inc. filed its Annual Report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission.  The 2024 Annual Report on Form 20-F can be downloaded fromwww.kbfg.com

2025-04-25 19:58 3404

X Financial Files Annual Report on Form 20-F for Fiscal Year 2024

SHENZHEN, China, April 25, 2025 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company" or "we"), a leading online personal finance company inChina, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission ("SEC"...

2025-04-25 19:27 3224

WATERDROP FILES ANNUAL REPORT ON FORM 20-F FOR FISCAL YEAR 2024

BEIJING, April 25, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ende...

2025-04-25 18:52 3346

Horizon Robotics and DENSO Forge Strategic Partnership to Accelerate Adoption of High-Performance Assisted Driving

SHANGHAI, April 25, 2025 /PRNewswire/ -- Horizon Robotics (stock code: 9660.HK), a leading provider of smart driving solutions for passenger vehicles, announced a strategic partnership with DENSO, a leading mobility supplier, to co-develop competitive assisted driving solutions. By combining Hori...

2025-04-25 18:34 2445

Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results

YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced its financial...

2025-04-25 18:05 3112

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors

CHENGDU, China, April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND) approval from the Center for Drug Evaluation (CDE) ...

2025-04-25 17:44 2086
1 ... 86878889909192 ... 777